With COVID-19 all over the news, many people have now heard the term ARDS bandied about. Acute respiratory distress syndrome (ARDS) is a very serious condition that a minority of people with COVID-19 develop. This is the reason, though, that everyone is discussing ‘flattening the curve’ as a way to decrease the number of patients on ventilators in the ICU at one time.
This is article explains what happens to the body in ARDS, and it goes into the genetic variants that increase or decrease the risk of ARDS (due to all causes – not just COVID-19). ARDS is a ‘syndrome’, and thus a collection of symptoms rather than a disease.
The intent here is to educate and inform – not to stress anyone out. There is a multitude of factors that influence the risk for ARDS with COVID-19, and genetics is only one part of the ARDS picture.
Acute Respiratory Distress Syndrome (ARDS) is a condition in which critically ill patients have acutely lowered oxygen levels, fluid in the lungs, and a need for positive pressure ventilation. ARDS is due to an uncontrolled inflammatory response injuring the lung tissue. [ref]
This syndrome was first defined in 1967, with updates periodically to the diagnosis criteria. The 2012 ARDS diagnosis definition includes that respiratory failure occurs without being explained by heart function and that oxygenation is needed at specific levels. [ref]
The most common causes of ARDS are pneumonia, sepsis, aspiration, and major trauma. The mortality rate is high for people with ARDS – from 35 – 36% mortality, depending on the severity.
Inside the lungs, you have the major airways (bronchi) that branch off into secondary bronchi. At the end of all the branching are alveoli – little sacks that are filled with air and surrounded by capillaries. This is where the exchange of oxygen and carbon dioxide takes place. Oxygen enters the bloodstream and carbon dioxide leaves.
These alveoli are lined with two types of epithelial cells that form a very tight barrier that only allows the passage of carbon dioxide and oxygen gasses. These tight junctions between the cells are important and created by specific proteins to create the bonds.
In ARDS, the epithelial cells lining the alveoli are no longer as tightly bound together, allowing them to be filled with fluid that leaks in from surrounding tissue. Once the alveoli are filled up, air can’t be exchanged. This causes both a decrease in oxygen and a buildup of carbon dioxide. [ref]
This is why just giving a patient more oxygen when they have ARDS doesn’t do any good. The alveoli aren’t able to make the exchange with the capillaries any more. Mechanical ventilation is needed in order to reopen and stabilize the alveoli.
So what causes the epithelial cells lining the alveoli to be damaged and no longer tightly joined together? There are a variety of different causes including:[ref]
When the epithelial cells are initially damaged, the body produces an immune response – sending in neutrophils and monocytes in to kill the pathogens. But this inflammatory response also damages the epithelial cells further. This is a second wave of damage that occurs in the lungs, due to our own immune response.
Capillaries leaking fluid: During ARDS, the capillaries surrounding the alveoli also play a role. The immune response causes increased permeability in the blood vessels, allowing plasma to leak out. This causes increased fluid around the alveoli, which combines with the decrease in epithelial cell barrier to flood the alveoli with fluid.
Finally, there is a long road to healing. The inflammatory response must be tamped down and the damaged lung tissue must be repaired. The recovery period can be extensive, with the patients continuing to have shortness of breath with exertion. [ref]
Looking at the genetic variants that increase the risk for ARDS is one way of knowing the pathways involved in this syndrome. Researchers can measure what is going on in the blood when someone has ARDS, and they can look at animal research models to see what goes on specifically in the alveoli. But genetics research can also show exactly which inflammatory molecules and which cellular junction molecules are involved both in the initial cascade of symptoms as well as the final steps needed to turn the corner and heal. Certain genetic variants are linked to an increased risk of having ARDS, and other variants are linked to a poorer outcome if someone has ARDS.
Vascular endothelial growth factor (VEGF) is produced in the cells that make up blood vessels (endothelial cells). They cause increased blood vessels to form and also mediate the permeability, or leakiness, of the blood cells. So while VEGF can be a part of the problem with fluid building up around the lungs, it can also be part of the repair process when the injured lungs are healing.[ref]
Genetic variants in the VEGF gene can cause a person to create more or less VEGF during normal circumstances. These variants are also linked to poor outcomes in ARDS.
Plasma levels of angiopoietin-2 (ANG2) are linked to increased endothelial permeability, allowing fluid to move out of the capillaries. Animal models show that increasing ANG2 causes a disruption of the epithelial barrier and causes lung injury. [ref]
TNF-alpha is a pro-inflammatory cytokine released for both acute infection and in chronic inflammation. Levels of TNF-alpha are increased in lung infections and COPD. [ref]
Interleukin-17 is another pro-inflammatory cytokine that is involved in amplifying inflammatory response by recruiting more monocytes and neutrophils to an area. Higher IL-17 is linked to an increased risk of ARDS. [ref]
Another part of the innate immune system is the complement system, which is activated to enhance the body’s ability to clear out microbes as well as damaged cells. Mannose-binding lectin is one way of activating the complement system. Low levels of mannose-binding lectin, due to an MBL2 genetic variant, increases the risk for septic shock and ARDS. [ref] [ref]
On the other hand, the overall picture on mannose-binding lectin and activation of the complement system isn’t entirely clear for the SARS coronavirus infections. Animal models here show that blocking the activation of the complement system lead to better outcomes for SARS coronavirus. [ref]
The stress on the lung cells – whether from a mechanical insult such as a ventilator at the wrong setting or from a bacterial or viral lungs – increases oxidative stress. One way that the body combats this is through increasing heme oxygenase-1, an enzyme that causes the reaction that converts heme (a pro-oxidant) into metabolites that are anti-inflammatory. Heme is part of the hemoglobin molecule and vital for transporting oxygen. At the core of the heme molecule is iron, which is very reactive. So when the body increases heme oxygenase-1 to convert heme, it helps to balance out oxidative stress. [ref]
Currently, medical professionals use therapy such as specific rates of ventilation and conservative fluid strategies to stop ARDS. The trials for pharmacological therapies are ongoing and target the inflammatory response. Additionally, trials using mesenchymal stem cells hold promise as well. [ref][ref][ref][ref][ref] There is hope for future treatments to reverse the course of ARDS.
For most people, COVID-19 infection will be asymptomatic or cause mild symptoms.
So what is the trigger for causing some people, mainly elderly people with co-morbidities, to progress to ARDS?
Keep in mind that ARDS is a syndrome, so it is really a collection of symptoms and not a specifically defined disease.
First, let’s take a look at the co-morbidities, or underlying health conditions, linked to COVID-19, especially in the elderly, include: [ref]
The virus that causes COVID-19 is now named SARS-CoV2, and it enters cells in the body through a receptor called ACE2 (angiotensin-converting enzyme 2). Cells in the lower respiratory tract have the ACE2 receptors on their surface. This allows the passage of the virus into the lung cells. [ref]
There are a number of different viral recognition receptors in the body that recognize the virus and then trigger MyD88 (below in the genetics section), which activates NF-κB, interferons, and several different inflammatory cytokines (also in the genetics section). This innate immune response needs to be regulated so that it doesn’t overwhelm the body. The infected lung cells are targeted, and if the initial infection isn’t cleared out, it can trigger “a series of immune responses and the production of cytokine storm in the body, which may be associated with the critical condition of COVID-19 patients.” [ref]
Initial data is showing that among COVID-19 patients that required ICU care, over 30% of them presented with ARDS. [ref]
So why are elderly people more prone to respiratory infections and pneumonia in general? According to the statistics from the 2017-2018 flu season, between 61,000 and 80,00 people (mostly elderly) died of the flu in the United States. Worldwide, there are about 200 million cases of viral community-acquired pneumonia every year, with children and the elderly being hit hardest. [ref]
The elderly are hit hard by the flu and cold viruses due to frailty, an inability to clear mucous well, and decline in the initial immune response. Senescence is the term applied to cells that are no longer functioning and needing to be cleared out of the body. Cellular senescence increases in older people, including senescence of immune cells (immunosenescence). This is one cause of the decrease in the ability of the immune system to clear out a viral infection quickly. “Infection is the primary cause of death in one third of individuals aged 65 years and over.” [ref]
Below are some of the genetic variants that research has shown to impact either susceptibility to ARDS or mortality in ARDS. These variants are linked with ARDS in general studies, not specific to COVID-19. Note that there are other genetic variants that influence ARDS (not found in 23andMe or AncestryDNA), so this is only giving you part of the genetic picture.
VEGFA gene: code for vascular endothelial growth factor which both increases the permeability of blood vessels (leakiness), but is also important for recovery from ARDS with repair and growth of blood vessels
Check your genetic data for rs3025039 936C>T (23andMe v4, v5; AncestryDNA):
Members: Your genotype for rs3025039 is —.
ANGPT2 gene: codes for ANG2, which increases the permeability (leakiness) of blood vessels
Check your genetic data for rs2442608 (23andMe v4; AncestryDNA):
Members: Your genotype for rs2442608 is —.
Check your genetic data for rs2442630 (23andMe v5):
Members: Your genotype for rs2442630 is —.
Check your genetic data for rs2515475 (23andMe v4):
Members: Your genotype for rs2515475 is —.
MBL2 gene: codes for mannose-binding lectin, which activates part of the immune response. Low levels are generally linked with an increased risk of infections.
Check your genetic data for rs1800450 (23andMe v4, v5; AncestryDNA):
Members: Your genotype for rs1800450 is —.
MyD88 gene: codes for a key activator of pro-inflammatory cytokines (NF-κB, TNF-alpha, and IL-6)
Check your genetic data for rs7744 (23andMe v4; AncestryDNA):
Members: Your genotype for rs7744 is —.
TNF gene: codes for TNF-alpha, important inflammatory cytokine
Check your genetic data for rs1800629 308G>A (23andMe v4, v5; AncestryDNA):
Members: Your genotype for rs1800629 is —.
Note that a different study found a decreased risk of getting ARDS in children with sepsis with the rs1800629 A-allele[ref]. The increased TNF-alpha production perhaps may be a risk factor in adults, but not children or elderly patients. More studies are needed to know for sure.
IL17 gene: codes for interleukin-17, an inflammatory cytokine
Check your genetic data for rs2275913 (23andMe v4, v5; AncestryDNA):
Members: Your genotype for rs2275913 is —.
NAMPT gene: codes for a rate-limiting enzyme in the NAD+ salvage pathway. It acts as a modulator in the immune system. [ref]
Check your genetic data for rs9770242 -1001T>G (23andMe v4; AncestryDNA):
Members: Your genotype for rs9770242 is —.
Normally in a Genetic Lifehacks article, this is where you would find a bunch of ‘lifehacks’ to modify the risk from the variants listed above. But that isn’t appropriate here… I don’t want to take a chance on leading anyone down the wrong path.
Viral Immunity: Your genes protect you
Your genetic variants shape your immune system and give you superpowers against some pathogens – and perhaps more susceptible to others.
Circadian Rhythm and Immune Response
Your circadian rhythm influences your immune response. Learn how this rhythm controls white blood cell production and why melatonin is important in protecting against viral and bacterial infections.
Interesting research studies:
Intro to the Immune system video: